Morgan Stanley Downgrades Sophia Genetics SA (SOPH) to Equalweight, 'Macro Weighs On Qtr/Guide'
Morgan Stanley analyst Tejas Savant downgraded Sophia Genetics SA (NASDAQ: SOPH) from Overweight to Equalweight with a price target ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)